Chimerix Share Price Today
(NASDAQ: CMRX)

Name: Chimerix Share Price Today (NASDAQ: CMRX) - Chimerix Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Chimerix share price is $8.46 & ₹735.76 as on 6 Mar 2025, 2.30 'hrs' IST

$8.46

▲

3.5

(70.56%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Chimerix share price in Dollar and Rupees. Guide to invest in Chimerix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Chimerix, along with analyst recommendations, forecasts, and comprehensive financials.

Chimerix share price movements

Today's Low: $8.40
Today's High: $8.47
$8.46
0.71%
Downside
Day's Volatility :0.83%
Upside
0.12%
52 Weeks Low: $0.75
52 Weeks High: $8.46
$8.46
91.13%
Downside
52 Weeks Volatility :91.13%
Upside
0.0%

Chimerix (CMRX) Returns

Period	Chimerix Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	476.74%	2.1%	0.0%
6 Months	464.21%	-4.1%	0.0%
1 Year	296.8%	2.2%	0.0%
3 Years	-7.81%	11.8%	-11.6%

Chimerix (CMRX) Key Statistics

in dollars & INR

Previous Close	$4.96
Open	$8.4
Today's High	$8.47
Today's Low	$8.4
Market Capitalization	$453.5M
Today's Volume	$326.0K
52 Week High	$8.47
52 Week Low	$0.75
Revenue TTM	$159.0K
EBITDA	$-92.7M
Earnings Per Share (EPS)	$-0.94
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-48.59%

How to invest in Chimerix Stock (CMRX) from India?

It is very easy for Indian residents to invest directly in Chimerix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Chimerix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Chimerix or CMRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Chimerix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Chimerix shares which would translate to 0.103 fractional shares of Chimerix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Chimerix, in just a few clicks!

Returns in Chimerix (CMRX) for Indian investors in Rupees

The Chimerix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Chimerix investment value today

Current value as on today

₹6,81,763

Returns

₹5,81,763

(+581.76%)

Returns from Chimerix Stock

₹5,76,800 (+576.8%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Chimerix (CMRX)

-6%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Chimerix Stock from India on INDmoney has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Chimerix

RA Capital Management, LLC
9.78%
Vanguard Group Inc
4.50%
Deerfield Management Co
4.19%
Rosalind Advisors, Inc.
3.39%
Monaco Asset Management
3.14%
Millennium Management LLC
2.84%

Analyst Recommendation on Chimerix

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Chimerix(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Chimerix Stock (CMRX)

What analysts predicted

Upside of 11.11%

Target:

$9.40

Current:

$8.46

Insights on Chimerix Stock (Ticker Symbol: CMRX)

Price Movement
In the last 3 months, CMRX stock has moved up by 476.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 129.0K → 26.0K (in $), with an average decrease of 79.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -20.68M → -22.87M (in $), with an average decrease of 10.6% per quarter
CMRX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 58.3%

Chimerix Technicals Summary

Sell

Neutral

Buy

Chimerix is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Chimerix (CMRX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Chimerix Inc	26.21%	464.21%	296.8%	-7.81%	210.0%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Chimerix Inc	0.48	NA	0.0	-1.0	-0.49	-0.3	NA	1.51
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Chimerix Inc	Buy	$453.5M	210.0%	0.48	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Chimerix

Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline products include ONC201 a program that is in Phase 3 clinical trial for treating patients with H3 K27M-mutant diffuse glioma, as well as in Phase 2 clinical trial for the treatment of rare neuroendocrine tumors; and ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist, which is in Phase 1 clinical trial for adult and pediatric patients with primary central nervous system tumors. The company also develops ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for oncology indications; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of SARS-CoV-2. It has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Organization	Chimerix
Employees	72
CEO	Mr. Michael T. Andriole M.B.A.
Industry	Health Technology

Management People of Chimerix

Name	Title
Mr. Michael T. Andriole M.B.A.	CEO, President & Director
Dr. Michael A. Alrutz J.D., Ph.D.	Senior VP, General Counsel & Corporate Secretary
Dr. Allen S. Melemed M.B.A., M.D.	Chief Medical Officer
Ms. Michelle LaSpaluto	Chief Financial Officer
Mr. Thomas J. Riga	Chief Operating & Commercial Officer
Mr. David Jakeman CPA	Vice President of Accounting & Finance
Dr. Joshua E. Allen Ph.D.	Chief Scientific Officer
Dr. Roy W. Ware M.B.A., Ph.D.	Chief Manufacturing Technology Officer

Important FAQs about investing in CMRX Stock from India :

What is Chimerix share price today?

Chimerix share price today stands at $8.46, Open: $8.40 ; Previous Close: $4.96 ; High: $8.47 ; Low: $8.40 ; 52 Week High: $8.46 ; 52 Week Low: $0.75.

The stock opens at $8.40, after a previous close of $4.96. The stock reached a daily high of $8.47 and a low of $8.40, with a 52-week high of $8.46 and a 52-week low of $0.75.

Can Indians buy Chimerix shares?

Yes, Indians can invest in the Chimerix (CMRX) from India.

With INDmoney, you can buy Chimerix at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Chimerix at zero transaction cost.

How can I buy Chimerix shares from India?

It is very easy to buy Chimerix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Chimerix (CMRX) be purchased?

Yes, you can buy fractional shares of Chimerix with INDmoney app.

What are the documents required to start investing in Chimerix stocks?

To start investing in Chimerix, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.